WASHINGTON--(BUSINESS WIRE)--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cigna Corp. (“Cigna” or the “Company”) (NYSE:CI), concerning the Company’s proposed acquisition by Anthem Inc. Under the terms of the proposal, Cigna shareholders will receive $188.00 for each share of Cigna common stock they own. At least one analyst has set a high target price of $190.00 for Cigna shares. The entire transaction is valued at approximately $54 billion. The invest
| < Prev | Next > |
|---|
